当前，新冠病毒与流感病毒交替或叠加流行，形成全球性公共卫生挑战。在此背景下，美国FDA相继批准了4款可用于自测的新冠甲乙流POCT自测产品（EUA），而我国新冠甲乙流联检自测产品尚未普及，呼吸道多病原检测仍以核酸为主，严重制约早期分级诊疗效率。随着公众健康意识提升和防疫策略升级，家庭自测需求增长，尤其是老年群体和年轻家庭需求愈加迫切，家庭自测也逐渐成为分级诊疗的重要环节。为此，复旦大学与上海市疾病...
Source Link当前，新冠病毒与流感病毒交替或叠加流行，形成全球性公共卫生挑战。在此背景下，美国FDA相继批准了4款可用于自测的新冠甲乙流POCT自测产品（EUA），而我国新冠甲乙流联检自测产品尚未普及，呼吸道多病原检测仍以核酸为主，严重制约早期分级诊疗效率。随着公众健康意识提升和防疫策略升级，家庭自测需求增长，尤其是老年群体和年轻家庭需求愈加迫切，家庭自测也逐渐成为分级诊疗的重要环节。为此，复旦大学与上海市疾病...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.